[go: up one dir, main page]

ATE149090T1 - MEDETOMIDINE COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION - Google Patents

MEDETOMIDINE COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION

Info

Publication number
ATE149090T1
ATE149090T1 AT92917469T AT92917469T ATE149090T1 AT E149090 T1 ATE149090 T1 AT E149090T1 AT 92917469 T AT92917469 T AT 92917469T AT 92917469 T AT92917469 T AT 92917469T AT E149090 T1 ATE149090 T1 AT E149090T1
Authority
AT
Austria
Prior art keywords
medetomidine
transdermal administration
compositions
salts
adhesive layer
Prior art date
Application number
AT92917469T
Other languages
German (de)
Inventor
Harry Jalonen
Arto Karjalainen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Application granted granted Critical
Publication of ATE149090T1 publication Critical patent/ATE149090T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Salts of medetomidine and optically active enantiomers, thereof, particularly the d-enantiomer are disclosed. These salts may be used to regulate the rate of the transdermal administration of active drugs. The transdermal delivery system comprises a drug impermeable backing layer and an adhesive layer wherein the medetomidine is dispersed throughout the adhesive layer.
AT92917469T 1991-05-31 1992-05-27 MEDETOMIDINE COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION ATE149090T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111732A GB9111732D0 (en) 1991-05-31 1991-05-31 The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs

Publications (1)

Publication Number Publication Date
ATE149090T1 true ATE149090T1 (en) 1997-03-15

Family

ID=10695876

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92917469T ATE149090T1 (en) 1991-05-31 1992-05-27 MEDETOMIDINE COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION

Country Status (17)

Country Link
US (1) US5438067A (en)
EP (1) EP0587819B1 (en)
JP (2) JP3483881B2 (en)
AT (1) ATE149090T1 (en)
AU (1) AU1798192A (en)
CA (1) CA2110161C (en)
DE (1) DE69217658T2 (en)
EE (1) EE03053B1 (en)
FI (1) FI104948B (en)
GB (2) GB9111732D0 (en)
IE (1) IE67168B1 (en)
LT (1) LT3130B (en)
LV (1) LV10047B (en)
NO (1) NO303818B1 (en)
NZ (1) NZ242717A (en)
WO (1) WO1992021338A1 (en)
ZA (1) ZA923395B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
IT1290255B1 (en) * 1997-02-05 1998-10-22 Wallcovering Pubblicita S R L SHAPED SUPPORT ADHERING TO THE SKIN FOR THE SALE OF COSMETIC OR PHARMACOLOGICAL SUBSTANCES AND METHOD FOR ITS MANUFACTURE
DE19936395C2 (en) 1999-08-03 2002-07-18 Antonia Buntz Cosmetic plasters and method for lifting the female breast by means of such a cosmetic plaster and its use
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
NZ596976A (en) * 2009-05-15 2014-05-30 Recro Pharma Inc Sublingual dexmedetomidine compositions and methods of use thereof
NZ601195A (en) * 2010-01-08 2015-02-27 Recro Pharma Inc Topical transdermal dexmedetomidine compositions and methods of use thereof
US20120202863A1 (en) * 2011-02-03 2012-08-09 Gerald Horn Compositions and methods for treatment of glaucoma
MX367286B (en) 2011-12-11 2019-08-13 Recro Pharma Inc Intranasal dexmedetomidine compositions and methods of use thereof.
RU2648449C2 (en) * 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
TWI624278B (en) * 2013-10-07 2018-05-21 帝國製藥美國股份有限公司 Methods and compositions for treating withdrawal syndromes using non-sedative dexmedetomidine transdermal compositions
CN105764495A (en) * 2013-10-07 2016-07-13 帝国制药美国公司 Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions
US20150098997A1 (en) * 2013-10-07 2015-04-09 Teikoku Pharma Usa, Inc. Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions
CN110585173A (en) * 2013-10-07 2019-12-20 帝国制药美国公司 Dexmedetomidine transdermal delivery device and methods of use thereof
US9974754B2 (en) 2013-12-18 2018-05-22 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
CN111346072B (en) * 2018-12-21 2022-05-27 宜昌人福药业有限责任公司 Transdermal drug delivery pharmaceutical composition and preparation method thereof
CN113784712A (en) 2019-05-01 2021-12-10 克雷西奥生物科技有限公司 Method for treating pruritus
WO2020222192A1 (en) 2019-05-01 2020-11-05 Clexio Biosciences Ltd. Methods of treating pruritus
TWI772807B (en) 2019-05-27 2022-08-01 日商救急藥品工業股份有限公司 External preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI864570A0 (en) * 1986-11-11 1986-11-11 Farmos Oy THERAPEUTIC ANVAENDBAR FOERENING.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
GB9111732D0 (en) 1991-07-24
IE67168B1 (en) 1996-03-06
DE69217658T2 (en) 1997-07-03
FI935351L (en) 1993-11-30
GB2256367A (en) 1992-12-09
FI104948B (en) 2000-05-15
NO303818B1 (en) 1998-09-07
JP2003327531A (en) 2003-11-19
NO934323L (en) 1993-11-29
NZ242717A (en) 1994-03-25
FI935351A0 (en) 1993-11-30
EP0587819B1 (en) 1997-02-26
DE69217658D1 (en) 1997-04-03
EP0587819A1 (en) 1994-03-23
LT3130B (en) 1994-12-25
CA2110161A1 (en) 1992-12-10
NO934323D0 (en) 1993-11-29
ZA923395B (en) 1993-03-31
US5438067A (en) 1995-08-01
WO1992021338A1 (en) 1992-12-10
LTIP112A (en) 1994-07-15
IE921937A1 (en) 1992-12-02
GB9211033D0 (en) 1992-07-08
LV10047B (en) 1995-02-20
JP3483881B2 (en) 2004-01-06
CA2110161C (en) 2004-08-03
LV10047A (en) 1994-05-10
AU1798192A (en) 1993-01-08
JPH06507888A (en) 1994-09-08
GB2256367B (en) 1995-03-15
EE03053B1 (en) 1997-12-15

Similar Documents

Publication Publication Date Title
DE69217658D1 (en) MEDETOMIDINE COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION
FI953533A0 (en) Transdermal therapeutic system with galantamine as active ingredient
DE3584766D1 (en) TRANSDERMAL SYSTEM FOR TIMOLOL.
FI905892A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV ETT TRANSDERMALT THERAPEUTIC SYSTEM, VILKET INNEHAOLLER BUPRENORFIN SOM AKTIV KOMPONENT.
PL307786A1 (en) Plaster for percutaneous administration of systemically acting steroid hormones
MY105074A (en) Transdermal therapeutical system comprising norpseudoephedrine as active component.
FI952269A0 (en) Skin-penetrating therapeutic system for application of physostigmine to the skin and method of preparation of the system

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee